Form 8-K - Current report:
SEC Accession No. 0001641172-25-003812
Filing Date
2025-04-11
Accepted
2025-04-11 16:05:16
Documents
17
Period of Report
2025-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43779
2 ex1-01.htm EX-1.01 190558
3 ex1-02.htm EX-1.02 182457
4 ex1-03.htm EX-1.03 19590
5 ex99-1.htm EX-99.1 19780
  Complete submission text file 0001641172-25-003812.txt   733677

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE scnx-20250408.xsd EX-101.SCH 3018
7 XBRL LABEL FILE scnx-20250408_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE scnx-20250408_pre.xml EX-101.PRE 24167
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3683
Mailing Address 2420 BRUNELLO TRACE LUTZ FL 33558
Business Address 2420 BRUNELLO TRACE LUTZ FL 33558 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39199 | Film No.: 25831559
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)